CLONIDINE (nda022499)- (EQ 0.09MG BASE/ML)

Generic Name	CLONIDINE	Innovator	TRIS PHARMA INC
Dosage	EQ 0.09MG BASE/ML
ParaIV Filing	No	505(b)2 Filing	Yes
Last Patent Expiry	Expired	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	Clonidine ER Oral Suspension is a central alpha-adrenergic agonist indicated for treatment of hypertension.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	17

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
EQ 0.09MG BASE/ML	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
No	0

Manufacturing Details of CLONIDINE